28438975|t|Galectin-3 is a target for proteases involved in the virulence of Staphylococcus aureus
28438975|a|Staphylococcus aureus is a major cause of skin and soft-tissue infection. The bacterium expresses four major proteases emerging as virulence factors; aureolysin (Aur), V8 protease (SspA), staphopain A (ScpA), and staphopain B (SspB). We hypothesized that human galectin-3, a β-galactoside-binding lectin involved in immune regulation and antimicrobial defense, is a target for these proteases, and that proteolysis of galectin-3 is a novel immune evasion mechanism. Indeed, supernatants from laboratory strains and clinical isolates of S. aureus caused galectin-3 degradation. Similar proteolytic capacity was found in Staphylococcus epidermidis isolates, but not Staphylococcus saprophyticus Galectin-3 -induced activation of the neutrophil NADPH-oxidase was abrogated by bacteria -derived proteolysis of galectin-3, and SspB was identified as the major protease responsible. The impact of galectin-3 and protease expression on S. aureus virulence was studied in a murine skin infection model. In galectin-3(+/+) mice, SspB - expressing S. aureus caused larger lesions and higher bacterial load than protease-lacking bacteria. No such difference was detected in galectin-3(-/-) mice, which also showed smaller lesion size as compared to the galectin-3(+/+) animals. In conclusion, the staphylococcal protease SspB inactivates galectin-3, abrogating its stimulation of oxygen radical production in human neutrophils and increasing tissue damage during skin infection.
28438975	0	10	Galectin-3	T116,T129	C0245382
28438975	16	22	target	T169	C1521840
28438975	27	36	proteases	T116,T126	C0030940
28438975	53	62	virulence	T038	C0042765
28438975	66	87	Staphylococcus aureus	T007	C0038172
28438975	88	109	Staphylococcus aureus	T007	C0038172
28438975	115	120	major	T080	C0205164
28438975	130	134	skin	T047	C0037278
28438975	139	160	soft-tissue infection	T047	C0149778
28438975	166	175	bacterium	T007	C0004611
28438975	176	185	expresses	T045	C1171362
28438975	191	196	major	T080	C0205164
28438975	197	206	proteases	T116,T126	C0030940
28438975	219	236	virulence factors	T109,T123,T131	C1136170
28438975	238	248	aureolysin	T116,T126	C0759663
28438975	250	253	Aur	T116,T126	C0759663
28438975	256	267	V8 protease	T116,T126	C0163582
28438975	269	273	SspA	T116,T126	C0163582
28438975	276	288	staphopain A	T116,T126	C1570150
28438975	290	294	ScpA	T116,T126	C1570150
28438975	301	313	staphopain B	T116,T126	C1313435
28438975	315	319	SspB	T116,T126	C1313435
28438975	343	359	human galectin-3	T116,T123	C3710772
28438975	363	391	β-galactoside-binding lectin	T116,T123	C0607430
28438975	404	421	immune regulation	T040	C1327458
28438975	426	447	antimicrobial defense	T201	C1456627
28438975	454	460	target	T169	C1521840
28438975	471	480	proteases	T116,T126	C0030940
28438975	491	502	proteolysis	T044	C0597304
28438975	506	516	galectin-3	T116,T129	C0245382
28438975	522	527	novel	T080	C0205314
28438975	528	542	immune evasion	T040	C1654934
28438975	543	552	mechanism	T169	C0441712
28438975	562	574	supernatants	T031	C1550101
28438975	580	598	laboratory strains	T059	C0487602
28438975	603	620	clinical isolates	T123	C3494793
28438975	624	633	S. aureus	T007	C0038172
28438975	641	651	galectin-3	T116,T129	C0245382
28438975	652	663	degradation	T044	C0597304
28438975	673	693	proteolytic capacity	T044	C1514570
28438975	707	733	Staphylococcus epidermidis	T007	C0038174
28438975	707	742	Staphylococcus epidermidis isolates	T123	C3494793
28438975	752	780	Staphylococcus saprophyticus	T007	C0318112
28438975	781	791	Galectin-3	T116,T129	C0245382
28438975	801	811	activation	T045	C0599177
28438975	819	829	neutrophil	T025	C0027950
28438975	830	843	NADPH-oxidase	T116,T126	C0068355
28438975	848	857	abrogated	T080	C0311403
28438975	861	869	bacteria	T007	C0004611
28438975	879	890	proteolysis	T044	C0597304
28438975	894	904	galectin-3	T116,T129	C0245382
28438975	910	914	SspB	T116,T126	C4043448
28438975	919	929	identified	T080	C0205396
28438975	937	942	major	T080	C0205164
28438975	943	951	protease	T116,T126	C0030940
28438975	952	963	responsible	T033	C1273518
28438975	969	975	impact	T080	C4049986
28438975	979	989	galectin-3	T116,T129	C0245382
28438975	994	1002	protease	T116,T126	C0030940
28438975	1003	1013	expression	T045	C1171362
28438975	1017	1026	S. aureus	T007	C0038172
28438975	1017	1036	S. aureus virulence	T034	C1829683
28438975	1054	1060	murine	T015	C0025929
28438975	1061	1075	skin infection	T047	C0037278
28438975	1076	1081	model	T050	C2986594
28438975	1086	1101	galectin-3(+/+)	T028	C1416831
28438975	1102	1106	mice	T015	C0025929
28438975	1108	1112	SspB	T116,T126	C4043448
28438975	1115	1125	expressing	T045	C1171362
28438975	1126	1135	S. aureus	T007	C0038172
28438975	1143	1157	larger lesions	T033	C0221198
28438975	1162	1183	higher bacterial load	T081	C2936404
28438975	1189	1205	protease-lacking	T169	C0011155
28438975	1206	1214	bacteria	T007	C0004611
28438975	1224	1234	difference	T080	C1705242
28438975	1239	1247	detected	T033	C0442726
28438975	1251	1266	galectin-3(-/-)	T028	C1416831
28438975	1267	1271	mice	T015	C0206745
28438975	1291	1298	smaller	T080	C0547044
28438975	1299	1310	lesion size	T082	C0449453
28438975	1330	1345	galectin-3(+/+)	T028	C1416831
28438975	1346	1353	animals	T008	C0003062
28438975	1358	1368	conclusion	T078	C1707478
28438975	1374	1397	staphylococcal protease	T116,T126	C0143587
28438975	1398	1402	SspB	T116,T126	C1313435
28438975	1403	1414	inactivates	T169	C0544461
28438975	1415	1425	galectin-3	T116,T129	C0245382
28438975	1427	1437	abrogating	T080	C0311403
28438975	1442	1453	stimulation	UnknownType	C0678668
28438975	1457	1471	oxygen radical	T123	C0178645
28438975	1472	1482	production	T169	C1522492
28438975	1486	1503	human neutrophils	T025	C0027950
28438975	1508	1518	increasing	T169	C0442808
28438975	1519	1532	tissue damage	T037	C0010957
28438975	1540	1554	skin infection	T047	C0162627